All Comments by Eric M. Reiman
- Proteins in Biofluids Foreshadow Dementia by 30 Years
- And Then There Were Three: Donanemab Phase 3 Trial Positive
- No Accelerated Approval for Donanemab
- Better Diagnosis with Blood Test Detecting Only Tau Made in Brain
- John Trojanowski, 75, a Giant in the Field of Neuropathology
- Amyloid Lurks in a Third of Cognitively Normal People Over 70
- Antisense Therapy Stifles CSF Tau in Mild Alzheimer’s Disease
- Forget Typical Alzheimer's: AI Finds Four Types.
- Earliest of Them All: Blood P-Tau231 Assay Flags Pre-Amyloid Alzheimer’s
- Plasma Aβ Test Wins Approval—Are p-Tau Tests Far Behind?
- ‘Reports of My Death Are Greatly Exaggerated.’ Signed, Aducanumab
- Cognitive Decline Trips Up API Trials of BACE Inhibitor
- Biogen/Eisai Halt Phase 3 Aducanumab Trials
- Roche Pulls Plug on Two Phase 3 Trials of Crenezumab
- PET Ligand Lights Up AAIC, May Detect Synapse Loss in AD